JR‐131, a Biosimilar of Darbepoetin Alfa, for the Treatment of Hemodialysis Patients With Renal Anemia: A Randomized, Double‐Blinded, Parallel‐Group Phase 3 Study

The aim of this study was to compare the efficacy and safety of intravenous JR‐131, a darbepoetin alfa biosimilar, to darbepoetin alfa in hemodialysis patients with renal anemia. In this 24‐week, multicenter, randomized, double‐blinded, parallel‐group phase 3 study, 334 hemodialysis patients with re...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishi, Shinichi, Yamada, Masayuki, Tsuruya, Kazuhiko, Masakane, Ikuto, Nakamoto, Hidetomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079119/
https://www.ncbi.nlm.nih.gov/pubmed/31325212
http://dx.doi.org/10.1111/1744-9987.13422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079119/
https://www.ncbi.nlm.nih.gov/pubmed/31325212
http://dx.doi.org/10.1111/1744-9987.13422

Ejemplares similares